USPTO serial 97107116
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $300
Philadelphia, PA, US
Philadelphia, PA, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David M. Kramer
David M. Kramer Buchanan Ingersoll & Rooney, P.C.1700 K Street N.W.Suite 300Washington, DC 20006| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing independent review of clinical trials for business purposes; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship | ACTIVE | — |
| 042 | Data automation and collection service using proprietary software to evaluate, analyze and collect service data; application service provider services featuring software for the collection, management and reporting by others of clinical research and marketing; providing a database featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing a website featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials; none of the aforesaid services relating to the custom design and development of computer hardware and software except as relating to medical research or medical clinical trials; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 27, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 6, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 2, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 1, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 6, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 6, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 14, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 4, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 5, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 5, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 5, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 5, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 23, 2024 | NOAC | CORRECTED NOA E-MAILED | — |
| Apr 23, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 22, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 22, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 17, 2024 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Apr 17, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2024 | INCD | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | — |
| Apr 8, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 20, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 20, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Mar 20, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 20, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Nov 22, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Nov 22, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 22, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 22, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 22, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 7, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 25, 2023 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Sep 25, 2023 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 25, 2023 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jun 26, 2023 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| May 23, 2023 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| May 22, 2023 | APET | ASSIGNED TO PETITION STAFF | — |
| May 4, 2023 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jan 20, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 3, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 3, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 14, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 29, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 29, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 25, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 25, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 13, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Oct 7, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Oct 3, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 23, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 18, 2022 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Mar 18, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 6, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 6, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 6, 2021 | NWAP | NEW APPLICATION ENTERED | — |